ALPHA 1 ANTITRYPSIN DEFICIENCY

Course overview

ALPHA-1 ANTITRYPSIN (AAT) DEFICIENCY IS A CLINICALLY UNDER-RECOGNIZED GENETIC DISORDER THAT CAUSES THE DEFECTIVE PRODUCTION OF ALPHA-1 ANTITRYPSIN PROTEIN. AAT PROTEIN PROTECTS THE BODY FROM THE NEUTROPHIL ELASTASE ENZYME, WHICH IS RELEASED FROM WHITE BLOOD CELLS TO FIGHT INFECTION. THIS ACTIVITY DISCUSSES THE EVALUATION AND MANAGEMENT OF AAT AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN MANAGING AND TREATING THE DISEASE TO IMPROVE PATIENT CARE.